Introducing VibioSphen, a brand dedicated to solving drug development problems in the field of infectious diseases. With over 7 years of expertise, VibioSphen offers a comprehensive range of products and services to boost your time to market and improve the quality of your results. As a Contract Research Organization (CRO) specialized in infectious diseases, VibioSphen embraces the One Health paradigm, which promotes a global effort to achieve the best solutions for human and animal health while considering the environment.

With a systemic approach, VibioSphen combines expertise in microbiology (Bacteria/Virus/Fungi) to contribute to the development of pharmaceutical compounds. The need for improved therapeutic solutions for infectious diseases is urgent, as they remain the leading cause of death in several countries, exacerbated by the rise of antibiotic resistance. VibioSphen, with its multidisciplinary team and integrated approaches, is committed to developing innovative solutions to combat infectious diseases.

Led by experienced professionals like Maxime Fontanié (Founder and CEO) and Dr. Patricia Martin (Chief Scientific Officer), VibioSphen offers support in the design of preclinical studies for the development of innovative anti-infective therapies. By joining forces and taking part in global efforts, VibioSphen aims to rejuvenate the antibiotic pipeline and discover novel strategies for priority pathogens.

With a team of dedicated scientists and professionals, VibioSphen is your trusted partner in the fight against infectious diseases